We want you to have the best possible experience and care and to have all the information you need. At San Diego Clinical Trials, our commitment to quality means you can be confident in the excellence of our research staff and our facility. We encourage you explore our site and tocontact ...
University Clinical Trials is a clinical research establishment that offers clinical studies for a variety of dermatologic conditions. Our principle investigator is a Board Certified Dermatologist, who is a fellowship trained in both Mohs Micrographic Su
San Diego, CA (United States) December 1-4, 2025 CTAD Sponsors KEYNOTES REGISTRATION CALL FOR ABSTRACTS TheClinical Trials on Alzheimer's Disease conference(CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and...
We invite you to review RCSD's actively enrolling retina clinical trials. Contact us today about enrolling in one of our targeted studies.
“Project REACH is an innovative initiative that will address the striking disparities seen in structural heart trials and research,” saidWayne Batchelor, MD, FACC, ACC Clinical Trials Research Program Co-Chair. “Through REACH there is a real opportunity to create meaningful change in how we det...
1. Visram A. Comparison of the efficacy in clinical trials versus ef fectiveness in the real-world of treatments for multiple myeloma: a population-based cohort study. Presented at: 65th American Society of Hematology Annual Meeting & Exposition; December 9-12, 2023; ...
Ninth annual meeting of the society for clinical trials: May 22–25, 1988 Town and Country Hotel San Diego, CAdoi:10.1016/0197-2456(87)90151-6CROSSREFControlled Clinical Trials
Information was obtained from the database maintained at the ClinicalTrials. gov website. AGE, advanced glycation end products; PARP, poly(ADP-ribose) polymerase; PPAR, peroxisome proliferator-activated receptor; RAGE, receptor of AGE; TNF, tumour necrosis factor; VEGF, vascular endothelial growth ...
We reported similar data in previous T1D trials [18, 19]. If Stem Cell Educator therapy only temporarily corrects the immune dysfunctions, the clinical efficacy in metabolic control should disappear soon after receiving Stem Cell Educator therapy, because of the short lifespans of most immune ...
SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the dosing of the first patient in the ...